PMID: 11325427Apr 28, 2001Paper

Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum

International Journal of Biological Macromolecules
Kiminori MatsubaraK Miyazawa

Abstract

An anticoagulant was isolated from a marine green alga, Codium cylindricum. The anticoagulant was composed mainly of galactose with a small amount of glucose, and was highly sulfated (13.1% as SO3Na). The anticoagulant properties of the purified anticoagulant were compared with that of heparin by assays of activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT) using normal human plasma. The anticoagulant showed similar activities with heparin, however, weaker than heparin. On the other hand, the anticoagulant did not affect PT even at the concentration at which APTT and TT were strongly prolonged. The anticoagulant did not potentiate antithrombin III (AT III) and heparin cofactor II (HC II), thus the anticoagulant mechanism would be different from that of other anticoagulants isolated so far from the genus Codium.

References

Feb 1, 1992·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·D S McLellan, K M Jurd
Oct 15, 1991·Thrombosis Research·S ColliecJ Jozefonvicz

❮ Previous
Next ❯

Citations

May 11, 2005·Journal of Materials Science. Materials in Medicine·W G LiuK D Yao
Apr 15, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gefei ZhouZuhong Xu
Nov 20, 2012·The Journal of Biological Chemistry·Paula V FernándezMarina Ciancia
Jan 5, 2008·Glycobiology·Eduardo H C FariasPaulo A S Mourão
Sep 18, 2008·Glycobiology·Vitor H Pomin, Paulo A S Mourão
Jul 20, 2010·Biochemistry. Biokhimii︠a︡·F V VityazevYu S Ovodov
May 14, 2011·Marine Drugs·Guangling JiaoH Stephen Ewart
May 21, 2011·Bioscience, Biotechnology, and Biochemistry·Sang-Won HongSoon-Sun Hong
May 20, 2015·Marine Drugs·Maria Filomena de Jesus RaposoRui Manuel Santos Costa de Morais
Sep 22, 2007·Journal of Bioscience and Bioengineering·Yunmian HeQuansheng Yao
Nov 13, 2015·Environmental Science and Pollution Research International·Esther Mbuci KinyuaJ C Ngila
Feb 5, 2015·Journal of Biochemical and Molecular Toxicology·Jun-Hui ChoiSung-Jun Kim
May 2, 2014·Environmental Toxicology and Pharmacology·Noel Vinay ThomasSe-Kwon Kim
Apr 20, 2013·International Journal of Biological Macromolecules·Mehdi TabarsaSangguan You
Feb 13, 2013·Carbohydrate Polymers·Manish JindalAshok K Tiwary
Apr 30, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nadia RuoccoMaria Costantini
Jul 3, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sweta R ChourasiaHatim F Daginawala
Aug 29, 2017·Microorganisms·Ariana A Vasconcelos, Vitor H Pomin
Dec 8, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Sirinya TayaRawiwan Wongpoomchai
Jun 16, 2011·Journal of the Science of Food and Agriculture·Rashmi C VinayakAnil Chatterji
Jul 2, 2019·Current Pharmaceutical Design·Ida Idayu MuhamadNurul Asmak Md Lazim
Jul 15, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Faiez HentatiPhilippe Michaud
May 17, 2019·Marine Drugs·Amandine AdrienNicolas Bridiau
Aug 14, 2020·International Journal of Biological Macromolecules·Pathum ChandikaWon-Kyo Jung
May 15, 2002·Carbohydrate Research·Amornrut ChaidedgumjornToshio Imanari
Oct 9, 2007·International Journal of Biological Macromolecules·Marina CianciaAlberto Saúl Cerezo
May 30, 2009·Carbohydrate Research·Jiraporn SuwanRobert J Linhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.